Thrombosis in the setting of cancer

MB Streiff - Hematology 2014, the American Society of …, 2016 - ashpublications.org
Venous thromboembolism (VTE) is a common cause of adverse outcomes in patients with
cancer. The risk of VTE varies with cancer type, stage and grade, cancer therapy, and …

Thrombosis in the setting of cancer

MB Streiff - Hematology, 2016 - pure.johnshopkins.edu
Venous thromboembolism (VTE) is a common cause of adverse outcomes in patients with
cancer. The risk of VTE varies with cancer type, stage and grade, cancer therapy, and …

[PDF][PDF] Thrombosis in the setting of cancer

MB Streiff - Hematology, 2016 - scholar.archive.org
Venous thromboembolism (VTE) is a common cause of adverse outcomes in patients with
cancer. The risk of VTE varies with cancer type, stage and grade, cancer therapy, and …

Thrombosis in the setting of cancer.

MB Streiff - … . American Society of Hematology. Education Program, 2016 - europepmc.org
Venous thromboembolism (VTE) is a common cause of adverse outcomes in patients with
cancer. The risk of VTE varies with cancer type, stage and grade, cancer therapy, and …

Thrombosis in the setting of cancer

MB Streiff - Hematology. American Society of Hematology …, 2016 - pubmed.ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is a common cause of adverse outcomes in patients with
cancer. The risk of VTE varies with cancer type, stage and grade, cancer therapy, and …

[HTML][HTML] Thrombosis in the setting of cancer

MB Streiff - Hematology: the American Society of Hematology …, 2016 - ncbi.nlm.nih.gov
Venous thromboembolism (VTE) is a common cause of adverse outcomes in patients with
cancer. The risk of VTE varies with cancer type, stage and grade, cancer therapy, and …

[引用][C] Thrombosis in the setting of cancer

MB Streiff - Hematology, 2016